ALHCNews Brief

Alignment Healthcare Jumps 16% After Medicare Pays More Than Wall Street Expected

Alignment Healthcare (ALHC) surged 16% to $21.66 after CMS announced 2026 Medicare Advantage rates that came in above what anyone had modeled.

The numbers
  • ALHC shares jumped 16% on the CMS rate announcement, outpacing the broader MA insurer rally
  • Stock trades at 30.7x forward earnings on $3.9bn TTM revenue
  • Next test: final 2026 rate notice confirmation and updated medical loss ratio guidance at earnings

What Actually Happened

CMS released its 2026 Medicare Advantage reimbursement rates, and the numbers came in higher than Wall Street expected. The entire MA complex moved: Centene, CVS Health, Elevance, and Clover Health all rallied. But ALHC's 16% pop says something specific about what happens when a pure-play bets right.

Alignment Healthcare is not a diversified insurer. It is a Medicare Advantage pure play. When CMS raises reimbursement rates, ALHC's revenue per member moves almost dollar-for-dollar. A diversified insurer like Elevance has commercial and Medicaid lines that absorb the swing. ALHC doesn't. That's why it moved more than the big names. Higher rates flow straight to the top line. For a company still growing its member base, each new member drops in at a better price.

The Catch

The preliminary rate notice is not the final rate notice. CMS publishes initial numbers, takes comments, and issues a final version. The final notice has historically landed close to the preliminary, but "close" can mean a lot when you're trading at 30.7x forward earnings. Every fraction of a percent matters at that multiple.

There's also the medical cost side of the equation. Higher reimbursement rates help, but they don't fix medical loss ratios on their own. If utilization trends run hot — and they have across the MA industry for the past two years — fatter rates get eaten by fatter claims. The number to watch at ALHC's next earnings isn't revenue growth. It's whether the gap between what CMS pays and what members cost is actually widening.

Bottom Line

This is genuinely good news for ALHC, and the stock deserved to move higher. But a 16% jump on a rate announcement prices in a lot of optimism for a company still proving it can scale profitably. The bull case is simple: more members, higher rates per member, operating leverage. The bear case is equally simple: 30.7x forward earnings for a health insurer requires near-flawless control of medical costs. Watch the medical loss ratio at next earnings. If it compresses, this rally has legs. If it doesn't, the multiple will come back down.

Alignment Healthcare doesn't have a Basis Report yet. Generate a full ALHC analysis here to dig into the membership trends and margin trajectory.

Basis Report does not hold positions in securities discussed. This is not investment advice.